Rewiring of oncogenic pathways confers carfilzomib resistance in multiple myeloma and is reversed by Rap1 inhibition
Acta Biochimica et Biophysica Sinica · 01.11.2026 · 58 (11) · 2556-2566
DOI: 10.3724/abbs.2026047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 20.05.2026. Verfasst von Linlin Qin und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Multiple Myeloma, Drug Resistance, Neoplasm, rap1 GTP-Binding Proteins, Oligopeptides. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Qin, L., Hu, R., Shi, Y., Li, Q., Gao, G., Zhang, X., Cheng, C., Li, B., & Zhuang, W. (2026). Rewiring of oncogenic pathways confers carfilzomib resistance in multiple myeloma and is reversed by Rap1 inhibition. Acta Biochimica et Biophysica Sinica, 58(11), 2556-2566. https://doi.org/10.3724/abbs.2026047
Vancouver
Qin L, Hu R, Shi Y, Li Q, Gao G, Zhang X, et al. Rewiring of oncogenic pathways confers carfilzomib resistance in multiple myeloma and is reversed by Rap1 inhibition. Acta Biochimica et Biophysica Sinica. 2026;58(11):2556-2566. doi:10.3724/abbs.2026047
BibTeX
@article{Qin2026,
author = {Qin, Linlin and Hu, Ruijing and Shi, Yilei and Li, Qi and Gao, Guangcan and Zhang, Xinyuan and Cheng, Chaowei and Li, Bingzong and Zhuang, Wenzhuo},
title = {Rewiring of oncogenic pathways confers carfilzomib resistance in multiple myeloma and is reversed by Rap1 inhibition},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
volume = {58},
number = {11},
pages = {2556--2566},
doi = {10.3724/abbs.2026047}
}
EUVIMED